Andrew A. Moshfeghi, MD

Perspiciatis quos qui ea quia totam qui. Laboriosam aut rerum optio minus iusto voluptates voluptatem. Veritatis voluptatem omnis adipisci tempora sit. Necessitatibus modi tempora sit et et ut pariatur dolores. Consequuntur sapiente minus quis placeat. Omnis accusantium magni debitis facilis. Facilis ab ut enim explicabo cum consectetur ut. Doloremque iure temporibus quae. Exercitationem blanditiis quae […]

Peter K. Kaiser, M.D.

Peter K. Kaiser, M.D., graduated magna cum laude with Highest Honors from Harvard College and Harvard Medical School. He completed an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute, Cleveland, Ohio. As a National Institute […]

Michael Goldstein, M.D.

Michael Goldstein, M.D., is President and Chief Medical Officer at Aurion Biotech, a clinical stage cell therapy company where he leads the clinical development, clinical operations, medical affairs, program management, manufacturing and quality teams. Before Aurion Biotech, Dr. Goldstein was President, Ophthalmology and Chief Medical Officer at Ocular Therapeutix (Nasdaq: OCUL), a developer of longer-duration […]